Showing 521 - 540 results of 4,739 for search '"malignancy"', query time: 0.06s Refine Results
  1. 521

    Approach to Breast Lesions with Radiology-pathology Discrepancy: Discussion Based on 3 Cases Diagnosed with Malignancy After Surgery by Sümeyra Emine Bölük, Gülçin Ercan, Leman Damla Ercan

    Published 2024-03-01
    “…Breast lesions are mainly classified as benign and malignant. When breast cancer is diagnosed, the patient is evaluated and a treatment plan is prepared. …”
    Get full text
    Article
  2. 522
  3. 523

    Examination of Physicians’ Perception of the Indications of Colorectal Stents in the Management of Malignant Large Bowel Obstruction: A Provincial Survey by Jean-Frédéric LeBlanc, Myriam Martel, Alan N. Barkun

    Published 2016-01-01
    “…Data are conflicting when assessing indications for colorectal self-expandable metallic stents (SEMS) in managing acute malignant large bowel obstruction (MLO). In November 2014, European and American Societies published guidelines to aid in understanding which patients might benefit from colorectal stenting. …”
    Get full text
    Article
  4. 524

    From Benign to Malign in a Case of Cervical Adenopathy in a 17-Year-Old Adolescent: Diagnostic Traps by Simona Dumitra, Maria Trailescu, Amelia Burlea, Claudia Covaci, Ozana Balan, Adrian Pavel, Carmen Crișan

    Published 2016-01-01
    “…Distinguishing between benign and malign adenopathies remains a challenge and could represent a source of error in a diagnosis. …”
    Get full text
    Article
  5. 525

    Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge by Bairu Shen, Zi Guo, Peng Huang, Minghua Tan, Xiaoshen Zhang, Siyao Lin, Changshan Song, Jiaqing Wang, Minqian Huang

    Published 2022-01-01
    “…Immunotherapy should be carefully selected for patients with combined malignancies after organ transplantation. Antivascular targeted therapy is one of the options worth considering; the risk of side effects of drug therapy is something that needs to be closely monitored when combined with immunotherapy.…”
    Get full text
    Article
  6. 526

    Why is Mouth Self-Examination Still Not Recommended for Early Detection of Oral Cancer and Oral Potentially Malignant Disorders? by Beatriz Monteiro da Silva, José Alexandre da Rocha Curvelo, Ruteléia dos Santos Assumpção Barroso, João Vitor Silveira de Azevedo, Andreia Cristina de Melo, Daniel Cohen-Goldemberg

    Published 2025-02-01
    “… Oral self-examination still remains enigmatic considering its functionality in detecting malignant disorders in the mouth. Although this tool is not concretely implemented in any health service, several studies have considered it as a real possibility for the screening and the early diagnosis of oral cancer. …”
    Get full text
    Article
  7. 527

    A New Challenging Strategy in the Prevention and Management of Tumor Lysis Syndrome in Patients with Chemo-Sensitive Hematological Malignancies by Ammar ELJack, Mohamad El Abdallah, Kadhim Al-Banaa, Kashif Chaudhry, Faisal Musa

    Published 2019-01-01
    “…It happens frequently in cancers receiving chemotherapy, particularly hematological malignancies. It can lead to death in severe cases. Tumor lysis syndrome that leads to acute renal failure requiring dialysis and/or ICU admission can be associated with a higher rate of complications and mortality. …”
    Get full text
    Article
  8. 528
  9. 529
  10. 530
  11. 531
  12. 532
  13. 533
  14. 534

    Diagnosis of Malignant Endometrial Lesions from Ultrasound Radiomics Features and Clinical Variables Using Machine Learning Methods by Shanshan Li, Jiali Wang, Li Zhou, Hui Wang, Xiangyu Wang, Jian Hu, Qingxiu Ai

    Published 2025-01-01
    “…Background: The prognosis of patients with early diagnosis of malignant endometrial lesions is good. We aimed to identify benign and malignant lesions in endometrial tissue, explore effective methods for assisting diagnosis, and improve the accuracy and precision of identifying endometrial lesions. …”
    Get full text
    Article
  15. 535
  16. 536
  17. 537

    Association Study between Novel CYP26 Polymorphisms and the Risk of Betel Quid-Related Malignant Oral Disorders by Shyh-Jong Wu, Yun-Ju Chen, Tien-Yu Shieh, Chun-Ming Chen, Yen-Yun Wang, Kun-Tsung Lee, Yueh-Ming Lin, Pei-Hsuan Chien, Ping-Ho Chen

    Published 2015-01-01
    “…Because the CYP26 polymorphisms associated with malignant oral disorders are not well known, we conducted an association study on the associations between the single nucleotide polymorphisms (SNP) of CYP26 families and the risks of malignant oral disorders. …”
    Get full text
    Article
  18. 538

    METTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by inactivating the Hippo/YAP signaling by Mei Pu, Xia Xiao, Shasha Lv, Daqing Ran, Qian Huang, Mingming Zhou, Qirong Lei, Lingshuang Kong, Qing Zhang

    Published 2025-01-01
    “…Moreover, lowering DLG2 expression mitigated the effects of METTL3 silencing on cervical cancer cell malignancy. Conclusion DLG2 acted as a tumor suppressor in cervical cancer by inhibiting the Hippo/YAP signaling pathway. …”
    Get full text
    Article
  19. 539
  20. 540